Answers are grounded in this paper and cite their sources.
The propensity of a mometasone-based triple combination treatment to cause steroid adverse effects on the facial skin should always be borne in mind when the same is prescribed as a treatment option in melasma.
No takes yet. Share an insight, caveat, or question.
Imran Majid (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: